Anton Xavier leads SVB’s efforts in NY and the Northeast supporting the creation and growth of early stage life science ventures.
Prior to SVB, Anton worked at the NY State Center for Biotechnology focusing on the development and implementation of technology and business development strategies to increase sponsored research, company formation, strategic alliances, and investment with external partners.
Prior to that Anton was with Pfizer where he had duties within the External Science and Innovation group (ES&I) focusing on sourcing, screening, and evaluating early through to late stage (inter)national biopharma ventures, entrepreneurial academic PI technology, private/public/local government funded life science initiatives, and funding vehicles which aligned with Pfizer’s R&D interest for investment and strategic partnerships. Additionally, Anton led efforts within Pfizer R&D from discovery through to late stage development of targeted therapeutics for oncology indications.
Anton’s academic experience has impacted a wide field of bioscience, including regenerative medicine, infectious disease, and cardiovascular biology where he developed multiple therapeutic, platform, and diagnostic innovations for military and industrial needs.